Related Experiment Video
Updated: Jun 2, 2026
12:36
Murine Precision-Cut Liver Slices as an Ex Vivo Model of Liver Biology
Published on: March 14, 2020
Deciphering the genetic predisposition to primary sclerosing cholangitis.
1Norwegian PSC Research Center, Clinic for Specialized Surgery and Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway.
Seminars in Liver Disease
|May 4, 2011
Summary
Genetic risk for primary sclerosing cholangitis (PSC) is linked to the major histocompatibility complex (MHC). New research reveals significant genetic overlap with other autoimmune diseases, suggesting shared pathogenic mechanisms.
Area of Science:
- Genetics
- Immunology
- Gastroenterology
Background:
- Genetic susceptibility loci for primary sclerosing cholangitis (PSC) have been primarily associated with the major histocompatibility complex (MHC) for decades.
- Establishing robust genetic associations outside the MHC region for PSC has been challenging.
- Recent genome-wide association studies (GWAS) indicate a substantial overlap in genetic risk loci between PSC and other autoimmune diseases beyond the MHC.
Purpose of the Study:
- To review and assess the robustness of known genetic susceptibility loci for PSC.
- To explore potential mechanistic roles of identified risk genes in PSC pathogenesis.
- To propose a model for PSC pathogenesis based on shared mechanisms with other autoimmune conditions.
Main Methods:
- Review of existing literature on genetic associations in PSC.
- Assessment of the strength and reliability of identified genetic risk loci.
- Genome-wide association analysis findings were considered to identify shared loci.
Main Results:
- Confirmed the historical association of the MHC region with PSC genetic risk.
- Identified a significant overlap of genetic risk loci outside the MHC that are also associated with other prototypical autoimmune diseases.
- Highlighted the need for further investigation into the functional roles of these shared genetic factors.
Conclusions:
- PSC shares genetic risk factors with other autoimmune diseases, suggesting common underlying pathogenic pathways.
- The primary insult in PSC may resemble tissue injury mechanisms seen in other autoimmune conditions.
- Understanding these shared genetic pathways offers potential for novel therapeutic strategies for PSC.
Related Concept Videos
01:21Chronic Pancreatitis II: Pathophysiology
Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
01:25Chronic Pancreatitis I: Introduction
Chronic pancreatitis is a long-standing, relapsing inflammation of the pancreas, characterized by irreversible damage to the gland. It results in progressive destruction of the pancreatic parenchyma, fibrosis, and eventual loss of both exocrine and endocrine function. The disease may evolve gradually after multiple episodes of acute pancreatitis or develop independently.EtiologyChronic pancreatitis can arise from a variety of causes:Alcohol use is the leading cause, accounting for 70–80% of...
01:24Chronic Pancreatitis I: Introduction
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
01:16Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...